Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajinomoto Animal Nutrition Europe, formerly known as Eurolysine, is a leading global producer of amino acids through large-scale microbial fermentation. Headquartered in Paris with a major manufacturing facility in Amiens, France, the company specializes in the production of high-quality amino acids such as L-Lysine, L-Threonine, and L-Tryptophan for the animal nutrition industry. Founded in 1974 as a joint venture, it is now a wholly-owned subsidiary of the Ajinomoto Group. The company leverages advanced biotechnology to provide sustainable nutritional solutions that improve animal growth and reduce environmental impact. Their operations are central to the European supply chain for essential nutrients used in livestock feed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurolysine.